Explore how expanding psychedelic clinical trials to include LGBTQ+ populations can address mental health disparities and foster inclusivity. This article underscores the urgent need for research that encompasses unique minority stressors, aiming for equitable and effective mental health interventions.

The post Expanding Psychedelic Clinical Trials to LGBTQ+ Populations appeared first on Psychedelics Today.

Previous articleAn Inside Look at the FDA and Early Drug Development
Next articleSelf-Care, Destabilization, and the Holistic Nature of Psychedelics